Avid Bioservices Return on Equity

Avid Bioservices (CDMO) currently reports a ROE of -339.34%. That is below the Healthcare sector average of 20.86%. Use the charts on this page to explore Avid Bioservices's ROE history and peer comparisons.

Avid Bioservices's ROE of -339.34% is lower than the Healthcare sector average of 20.86%. That is roughly 1727.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Avid Bioservices's current -339.34% should be judged against Healthcare norms (sector average: 20.86%) and against CDMO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -339.34%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.86%. From there, open related valuation or income-statement pages for Avid Bioservices, and consider following CDMO for alerts when major investors trade the stock.

Avid Bioservices is classified in the Healthcare sector. On ROE, it currently shows -339.34% versus a sector average near 20.86%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDMO with unrelated industries.